Skip to main content

Vitiligo STOP-V1

Status: Closed to Enrollment

Study Details

View study details on clinicaltrials.gov.

Locations

  • Sunnyvale

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Amit Pandya
Amit Pandya
Principal investigator
View Profile

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?